Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: CD147 promotes breast cancer migration and invasion by inducing epithelial-mesenchymal transition via the MAPK/ERK signaling pathway

Fig. 2

Transfection efficiency of the different constructs in BT549 and MCF-7 cells. (A) qRT-PCR results show consistent CD147 expression in BT549, BT549-liposome, and BT549-liposome-vector cells, with successful upregulation in BT549-liposome-CD147. (B) Western blot confirms increased CD147 protein expression in BT549-liposome-CD147. (C) qRT-PCR demonstrates CD147 knockdown in MCF-7-liposome-si-CD147. (D) Western blot confirms reduced CD147 protein expression in MCF-7-liposome-si-CD147. **P < 0.01, vs. BT549/MCF-7; ##P < 0.01, vs. BT549-liposome/MCF-7-liposome; &&P < 0.01, vs. BT549-liposome-CD147/MCF-7-liposome-siNC

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us